CounterACT NIH Translational Grant Awarded to the Mohan lab

The eye is one of the most sensitive organs that can be injured by toxic chemicals and warfare agents, but drug treatments to mitigate chemical-induced ocular pathology have not been developed.  Alerted to increased threats posed by homeland terrorists who could cause mass casualty by chemical exposure, the trans NIH-agency CounterACT program was developed to fund cutting-edge research to combat bodily injury (  Dr. Mohan is a recipient of a National Eye Institute grant titled “Unraveling the corneal and retinal mechanisms of chemical injury” to expand his research on novel therapeutic targets in the eye for such chemical emergencies.

team Mohan